BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

23 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
THIAZOLO[5,4-B]PYRIDINE MALT-1 INHIBITORSBDB
Abbvie
Pyridine quinoline compounds as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunctionBDB
Vanderbilt University
Tosylacetate based compounds and derivatives thereof as PHGDH inhibitorsBDB
Boehringer Ingelheim International
Inhibitor of apoptosis protein (IAP) antagonistsBDB
Sanford Burnham Prebys Medical Discovery Institute
Amino-fluoropiperidine derivatives as kinase inhibitorBDB
Daewoong Pharmaceutical
Heteroaryl amides as inhibitors of protein aggregationBDB
Ucb Biophama
Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CLBDB
Cleveland Clinic
Antitumor drug for intermittent administration of FGFR inhibitorBDB
Taiho Pharmaceutical
Thienopyrazine carboxamides as ubiquitin-specific protease inhibitorsBDB
Valo Early Discovery
Acetamide thienotriazolodiazepines and uses thereofBDB
Dana-Farber Cancer Institute
Structure-Guided Design of Conformationally Constrained Cyclohexane Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 3CL Protease.BDB
Wichita State University
PPARG modulators for the treatment of osteoporosisBDB
The Scripps Research Institute
Neprilysin inhibitorsBDB
Theravance Biopharma R&D Ip
Pyrazolo pyrimidine derivatives and their use as MALT1 inhbitorsBDB
Novartis
Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereofBDB
Pfizer
Kinase inhibitors and method of treating cancerBDB
University Health Network
Synthesis and paroxonase activities of novel bromophenols.BDB
Ataturk University
1H-[1,2,3]triazolo[4,5-c]pyridine-4-carbonitrile derivativesBDB
Merck Sharp & Dohme
Benzofuran derivatives for the treatment of hepatitis CBDB
Bristol-Myers Squibb
Synthesis and molecular modelling studies of novel sulphonamide derivatives as dengue virus 2 protease inhibitors.BDB
Birla Institute of Technology
Pyridonemorphinan analogs and biological activity on opioid receptorsBDB
Purdue Pharma
Thiazolidinedione derivative and use thereofBDB
Industry-Academic Cooperation Foundation, Chosun University
In vitro pharmacological profile of a novel structural class of oxytocin antagonists.BDB
Merck Sharp & Dohme Research Laboratories